Researchers reported on Nurr1 as a promising therapeutic target for managing Parkinson’s disease (PD).
Experimental treatment for metastatic pancreatic cancer shows promise in phase 2 clinical trial
Clinicians at Georgetown University’s Lombardi Comprehensive Cancer Center reported promising preliminary findings based on outcomes in the first six patients with metastatic pancreatic cancer enrolled